Another tech titan is partnering with a life sciences company to help patients with a difficult-to-treat disease. This time, Teva Pharmaceutical Industries Ltd. and Santa Clara, Calif.-based Intel are teaming up to develop a wearable device intended to continuously monitor and analyze Huntington's disease symptoms.

Never a dull moment in the world of medical devices and the Food and Drug Administration, is there? Sometimes the FDA is on the march, other times it seems the agency is about to be eclipsed by other forces. Don't be fooled by the picture on the left, though. There is no FDA airline, or any intent by the agency to regulate airlines (none that we know of, anyway) other than the food they serve on board. A case of regulatory leapfrog? Device flight is the term used...

The U.S. isn't likely to buy into several recommendations in a new report by the UN High-Level Panel on Access to Medicines that narrowly focuses on patents as the barrier to access to drugs and devices across the world.